AMANDA SWEET: Open Payments
NPI 1861882508 · JACKSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$875 in 66 payments from 16 companies in 2025. Trend: 2023 $704 · 2024 $1,022 · 2025 $875
Food & beverage: $875
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $178 |
| Novo Nordisk Inc | 13 | $168 |
| Lilly USA, LLC | 6 | $102 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| Amgen Inc. | 4 | $62 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Astellas Pharma US Inc | 2 | $33 |
| Corcept Therapeutics | 2 | $33 |
Products named: Wegovy, MOUNJARO, UBRELVY, VRAYLAR, OTEZLA, Symbravo, CAPLYTA, QULIPTA.
Industry payments across NC — which companies pay providers there.
